REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wanjia Group Holdings Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wanjia Group Holdings Limited Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Wanjia Group Holdings Ltd is a wholesaler and distributor and retail chain operator of pharmaceutical and healthcare products in Fujian Province ofChina.

Headquarters
Room 1902, 19Th Floor, 101 King'S Road
Hong Kong; Hong Kong;

Contact Details: Purchase the Wanjia Group Holdings Limited report to view the information.

Website: http://www.wanjia-gp.com

Basic Information
Total Employees:
Purchase the Wanjia Group Holdings Limited report to view the information.
Outstanding Shares:
Purchase the Wanjia Group Holdings Limited report to view the information.
Registered Capital:
Purchase the Wanjia Group Holdings Limited report to view the information.
Financial Auditors:
Purchase the Wanjia Group Holdings Limited report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
28%
Purchase this report to view the information.
28%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Fujian Huihao Sihai Pharmaceutical China Company Limited (China)
Fujian Huiming Medicine Co. Limited (China)
Fuzhou Province Huihao City Huihao Pharmaceutical Co. Limited (China)
Company Performance
Financial values in the chart are available after Wanjia Group Holdings Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
4.25%▲
Total operating revenue
4.25%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-32.49%▼
Total equity
-37.46%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.71%▼
Quick Ratio
-0.03%▼
Cash Ratio
0.34%▲

Similar companies

China Resources Pharmaceutical Group Ltd
 
Fosun International Limited
CSPC Pharmaceutical Group Limited
 
Sino Biopharmaceutical Limited
China Traditional Chinese Medicine Holdings Co. Limited
 
United Laboratories International Holdings Limited
China NT Pharma Group Company Limited
 
Sanai Health Industry Group Company Limited
MediNet Group Limited (Hong Kong) (医汇集团有限公司 (香港))
 
Antengene Corporation Limited
Mabpharm Limited
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo